Cur­rax dou­bles down on ‘pi­o­neer’ weight-loss med Con­trave in new­ly en­er­gized obe­si­ty drug mar­ket

Obe­si­ty is in the spot­light thanks to a raft of new and pend­ing ther­a­pies in the pipeline. How­ev­er, Cur­rax Phar­ma­ceu­ti­cals’ Con­trave, the old guard of weight loss meds, isn’t ced­ing its vet­er­an sta­tus.

In fact, it’s dou­bling down on Con­trave as an op­tion with the launch of a new brand cam­paign “One Size Does Not Fit All.” The dig­i­tal ef­fort high­lights the idea that dif­fer­ent so­lu­tions fit dif­fer­ent peo­ple, and in­cludes the brand web­site along with dig­i­tal and so­cial me­dia ads and posts, med­ical jour­nal ads and ed­u­ca­tion and in-of­fice ma­te­ri­als.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER